Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
14,177,872
-
Share change
-
+641,450
-
Total reported value
-
$953,180,000
-
Put/Call ratio
-
501%
-
Price per share
-
$67.23
-
Number of holders
-
65
-
Value change
-
+$43,321,207
-
Number of buys
-
41
-
Number of sells
-
20
Institutional Holders of CHINA BIOLOGIC PRODS INC - COM (CBPO) as of Q4 2014
As of 31 Dec 2014,
CHINA BIOLOGIC PRODS INC - COM (CBPO) was held by
65 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,177,872 shares.
The largest 10 holders included
Warburg Pincus LLC, Visium Asset Management, LP, RENAISSANCE TECHNOLOGIES LLC, FIL Ltd, MORGAN STANLEY, MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC, RUDMAN ERROL M, Davidson Kempner Capital Management LP, DEUTSCHE BANK AG\, and UBS Group AG.
This page lists
65
institutional shareholders reporting positions in this security
for the Q4 2014 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.